vimarsana.com
Home
Live Updates
Apollomics Presents Vebreltinib Data at the 2024 American As
Apollomics Presents Vebreltinib Data at the 2024 American As
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Preclinical studies demonstrate vebreltinib is effective for a variety of tumor types carrying MET-driver alterations, and effective for overcoming MET-amplification dependent resistance to EGFR...
Related Keywords
San Diego ,
California ,
United States ,
China ,
Kunpeng ,
Guangdong ,
American ,
Sean Leous ,
Guo Liang Yu ,
Peter Vozzo ,
Securities Exchange ,
European Society Of Medical Oncology Congress On ,
Exchange Commission ,
Apollomics Inc ,
American Association For Cancer Research ,
Avistone Biotechnology Co ,
National Medical Products Administration ,
Cancer Research ,
Annual Meeting ,
Chief Executive Officer ,
Avistone Biotechnology ,
Medical Oncology Congress ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Markets ,